chartexchange

PTN
Palatin Technologies, Inc. Common Stock
stockNASDAQ

At CloseNov 19, 2026 3:38:48 PM EST
4.95USD-4.440%(-0.23)13,864
After-hoursNov 19, 2026 4:00:30 PM EST
4.93USD-0.404%(-0.02)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Carl Spana
HQ
Cranbury, NJ, USA
Previous Close
$5.15
Beta
0.89
52-Week High
$31.00 2025-12-15
52-Week Low
$4.51 2026-10-28
SMA 50
$7.64
SMA 200
$13.31
Avg. Vol 10D
36,924
Avg. Vol 30D
37,975
Avg. Vol 90D
56,411
Relative Vol
0.37
1.56M
33.4800%
2,209
Aug 31, 2022 · 1-for-25 (reverse)
PTN Profile

palatin technologies, inc., a specialized biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the united states. the company's lead product is vyleesi, a melanocortin receptor agonist for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. it is also developing oral pl8177, a selective melanocortin receptor (mcr) 1 agonist peptide that has completed phase i clinical trial for the treatment of inflammatory bowel diseases; and systemic pl8177, which has completed phase i clinical trial for treating non-infectious uveitis and covid-19. in addition, the company engages in the development of pl9643, a peptide melanocortin agonist active at multiple mcrs, including mc1r and mc5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. further, it is developing pl3994, a natriuretic peptide receptor (npr)-a agonist and sy

PTN Performance
PeriodPriceDateChangeBeta
1W6.232026-11-13-21.35%-1.894
1M5.522026-10-20-11.23%2.755
3M10.202026-08-20-51.96%2.423
6M14.592026-05-20-66.42%1.108
1Y14.492025-11-20-66.18%0.887
2Y0.912024-11-20+435.99%—
5Y9.002021-11-19-45.57%0.165
PTN Stock Summary

Palatin Technologies, Inc. Common Stock (NASDAQ:PTN) stock price today is $4.90, and today's volume is 13,886. PTN is down 4.854% today. The 30 day average volume is 37,975. PTN market cap is $8.73M with 1.78M shares outstanding.